Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01386892 · ClinicalTrials.gov registry record
Immunological Characterization of Blood of Normal Individuals
A clinical trial of Heathly Volunteers, sponsored by Ohio State University.
- Completed
- Registry status
- 1,300
- Enrollment target
- 1
- Study location
NCT01386892 is a study of Heathly Volunteers that has completed, run by Ohio State University. The registered enrollment target is 1,300 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01386892, a study of Heathly Volunteers, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 1,300 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to obtain normal samples of blood, saliva and urine to serve as controls for other approved protocols and for analysis. These include determination of the functional capabilities of cells, proteins, nucleic acids and microvesicles obtained from peripheral blood including plasma, serum and cellular fraction from normal individuals. Saliva and urine will have similar testing which may also be compared to the blood testing results. The ongoing objective varies from investigation to investigation but in general the investigational goals are to better understand the immune function of normal volunteers and compare it to immune function in disease states.
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,300 participants |
| Start Date | 2011-03-01 |
| Est. Completion | 2015-01-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01386892
The ClinicalTrials.gov registry entry for NCT01386892 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heathly Volunteers appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT01386892 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT01386892 about?
NCT01386892 is a clinical study titled "Immunological Characterization of Blood of Normal Individuals". This study seeks to obtain normal samples of blood, saliva and urine to serve as controls for other approved protocols and for analysis. These include determination of the functional capabilities of cells, proteins, nucleic acids and microvesicles obtained from peripheral blood including plasma, ser...
What is the current status of trial NCT01386892?
This trial is currently completed. The enrollment target is 1,300 participants. The study started on 2011-03-01. Estimated completion is 2015-01-05.
What conditions does trial NCT01386892 study?
This clinical trial studies the following conditions: Heathly Volunteers.
What interventions are being tested in trial NCT01386892?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT01386892?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01386892 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.